Astellas Pharma Canada Inc.
Registration:
4
of
4
(2019-03-01
to
2020-01-14)
Policies or Program
- Health Canada guidance or other initiatives with respect to safety considerations relating to the use of human tissue, cells, and organs for transplantation
- Health Canada’s general mandate and role with respect to promoting patient safety
- Innovation, Science and Economic Development Canada tracking and analysis of biopharmaceutical sector trends and developments
Regulation
- Food and Drugs Act Regulations with respect to the approval and life-cycle management of therapeutic products